跳至主要内容
临床试验/EUCTR2008-003696-43-NL
EUCTR2008-003696-43-NL进行中(未招募)不适用

Prevention of progression of duodenal adenomas to cancer in patients with familial adenomatous polyposis - Duodenal adenomas and cancer in patients with FAP

KWF Kankerbestrijding0 个研究点开始时间: 2008年11月11日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Patients with FAP with duodenal adenomas Spigelman stage II and III, under regular controle in one of 4 participating University hospitals.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • - History of cardiovascular incident
  • - Cholelithiasis
  • - History of gastric or duodenal ulcera
  • - Allergic reaction to NSAIDs or UDCA
  • - Renal function disturbance, creat clearance <50ml/min
  • - Liver function disturbance, albumin <25g/l or Child-Pugh-score > or = 10
  • - Use of NSAIDs or UDCA during enrolment
  • - Cardiac patients NYHA class II-IV
  • - Age below 18 or above 70 years or incapable of signing informed consent

研究者

发起方
KWF Kankerbestrijding

相似试验